Clinical Trial Update: Sota-ES - Sotatercept in Patients With Congenital Heart Disease and Eisenmenger´s Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sotatercept in patients with congenital heart disease and Eisenmenger syndrome is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Eisenmenger Syndrome
• Pulmonary Arterial Hypertension

Drugs mentioned

• Sotatercept (sotatercept)

Snippet

Sponsor: Philipps University Marburg | Conditions: Congenital Heart Disease (CHD), Eisenmenger Syndrome | Phase 2 | Status: NOT_YET_RECRUITING